Cargando…

The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations

The neuropharmacology of marijuana, including its effects on selective serotonin reuptake inhibitor (SSRI)/antidepressant metabolism and the subsequent response and tolerability in youth, has received limited attention. We sought to (1) review clinically relevant pharmacokinetic (PK) and pharmacodyn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaughn, Samuel E., Strawn, Jeffrey R., Poweleit, Ethan A., Sarangdhar, Mayur, Ramsey, Laura B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307883/ https://www.ncbi.nlm.nih.gov/pubmed/34209709 http://dx.doi.org/10.3390/jpm11070615

Ejemplares similares

Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents
por: Strawn, Jeffrey R., et al.
Publicado: (2023)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications
por: Poweleit, Ethan A., et al.
Publicado: (2022)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
por: Aldrich, Stacey L., et al.
Publicado: (2019)

Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actions
por: Cooper, Takesha, et al.
Publicado: (2023)

Surgical considerations of marijuana use in elective procedures
por: Huson, Henry B., et al.
Publicado: (2018)

Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing
por: Bishop, Jeffrey R.
Publicado: (2021)

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

Site readiness practices for clinical trials – considerations for CTSA hubs
por: Viera, Laura, et al.
Publicado: (2023)

Antidepressants and Advertising: Psychopharmaceuticals in Crisis
por: Greenslit, Nathan P., et al.
Publicado: (2012)

Perspectives of illicit marijuana growers and traders on commercial legalisation of marijuana in South Africa: considerations for policy formulation
por: Manu, Emmanuel, et al.
Publicado: (2021)

Prenatal Tobacco, Marijuana, Stimulant, and Opiate Exposure: Outcomes and Practice Implications
por: Minnes, Sonia, et al.
Publicado: (2011)

The role of dissociation in ketamine’s antidepressant effects
por: Ballard, Elizabeth D., et al.
Publicado: (2020)

Maximizing biomedical research impacts through bioethical considerations
por: Tornini, Valerie A., et al.
Publicado: (2023)

High-quality antidepressant prescribing: please consider whether “perfection is the enemy of progress”
por: Walkup, John T., et al.
Publicado: (2020)

Current perspectives on the antidepressant-like effects of guanosine
por: Bettio, Luis E. B., et al.
Publicado: (2016)

Consideration of compound drivers and impacts in the disaster risk reduction cycle
por: van den Hurk, Bart J.J.M., et al.
Publicado: (2023)

Clinical considerations of lipid target and goal in dyslipidemia control
por: Wu, Na-Qiong, et al.
Publicado: (2016)

Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations
por: Talib, Mays, et al.
Publicado: (2020)

Marijuana Use and Dependence in Chilean Adolescents and Its Association with Family and Peer Marijuana Use
por: Lobato, Mónica, et al.
Publicado: (2016)

Considerations for assessing the impact of the COVID-19 pandemic on mental health in Australia
por: Tan, Eric J, et al.
Publicado: (2020)

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations
por: Petersen, Ronald C., et al.
Publicado: (2023)

Modeling and Simulation in Clinical Pharmacology and Dose Finding
por: Staab, A, et al.
Publicado: (2013)

The potential and pitfalls of artificial intelligence in clinical pharmacology
por: Johnson, Martin, et al.
Publicado: (2023)

Suicide Rates and Antidepressant Prescribing: A Casual or Causal Relationship?
por: Baune, Bernhard, et al.
Publicado: (2006)

Are Drinking Cognitions Associated with Marijuana and Concurrent Alcohol and Marijuana Use among Adolescents and Young Adults?
por: Pritschmann, Ricarda K., et al.
Publicado: (2022)

Aberrant orbitofrontal connectivity in marijuana smoking adolescents
por: Lopez-Larson, Melissa Patricia, et al.
Publicado: (2015)

Cardiac Ischemia Associated With Marijuana Use in an Adolescent
por: Schreier, Matthew D, et al.
Publicado: (2020)

Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta‐analysis
por: Sarvet, Aaron L., et al.
Publicado: (2018)

Development of a Multidisciplinary Clinic for Patients with Ehlers Danlos Syndromes: Considerations and Strategies
por: Black, William R, et al.
Publicado: (2023)

The World Health Organization Prequalification Program and Clinical Pharmacology in 2030
por: Blaschke, Terrence F., et al.
Publicado: (2019)

Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma
por: Fresnais, Margaux, et al.
Publicado: (2021)

FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?
por: Peterson, MC, et al.
Publicado: (2015)

Prospective, longitudinal study to isolate the impacts of marijuana use on neurocognitive functioning in adolescents
por: Ren, Wen, et al.
Publicado: (2023)

Online Methods for Locating Medical Marijuana Dispensaries: Practical Considerations for Future Research
por: Pedersen, Eric R., et al.
Publicado: (2018)

Marijuana Use, Recent Marijuana Initiation, and Progression to Marijuana Use Disorder Among Young Male and Female Adolescents Aged 12–14 Living in US Households
por: Forman-Hoffman, Valerie L, et al.
Publicado: (2017)

Recruiting the Immune System Against Disease: Lessons for Clinical and Systems Pharmacology
por: Vicini, Paolo, et al.
Publicado: (2019)

Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies
por: Li, Junyi, et al.
Publicado: (2019)

A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development
por: Bai, Jane P. F., et al.
Publicado: (2020)

Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective
por: Perazzolo, Simone, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tu43dpdgqle9gqm6ccvfkk1t3m